Hope all of you have had a restful weekend! It’s now time to have an overview of some upcoming IP events and opportunities to kick start the new week.
OPPORTUNITY
King’s College London – Lecturer or Senior Lecturer in Intellectual Property Law
The Dickson Poon School of Law is seeking a candidate for the role of Lecturer or Senior Lecturer with research and teaching expertise in Intellectual Property law. For more information about this position, please refer to the link here.
EVENTS
1 June 2022 (13:00 to 17:30 CEST) – Stockholm Intellectual Property Law Review - From open access to open science – The interface between IP, academia and the market (Stockholm, Sweden)
The annual in-person conference of the Stockholm Intellectual Property Law Review will discuss the current status of open access for research and academia, as well as future developments involving the access and creation of new IP in such platforms.
The event is free to join. For more information, please refer to the link here.
16 September 2022 (12:00 to 18:00 BST) - CeBIL Annual Symposium 2022 – Intellectual Property and Drug Repurposing: New Frontiers (University of Cambridge, UK and online)
The Cambridge Centre for Law, Medicine and Life Sciences (LML), in collaboration with the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen, will be organizing a symposium on drug repurposing. The symposium will discuss studies on the number of patents for repurposing, which were recently published in Nature Biotechnology, and pilot programmers in the EU and UK to promote repurposing.
The event is free to join, and it will be in hybrid format. For more information, please refer to the link here.
Reviewed by James Kwong
on
Monday, May 30, 2022
Rating:
Follow the IPKat on LinkedIn 
![[Guest post] Asking ourselves ‘Y’ – Are shape marks shaping complex products’ aftermarkets?](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhHwE0es_m0lzJpedp0KFtKOYBne_M3YPJ-qwQxiY_YMkHffLAAXkSW9F-pjQFKsy5kJJ-VWScQQkuEVb5-BxnDv10XIMAbYhvgzBSQadD1gdTiIjg9-Oj9Iekll-C3Ca9I76uI3Hh5nCI4QyLosLSNev9VzLq9lF1jM86ungheEDOBKLzGTbE3yw/s72-c/Picture%201.png)
![[Guest post] Flat rates supported by clauses on universality of repertoire in contracts between CMOs and users are anti-competitive, says Spanish Competition Authority](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhpBg7o3d7DPzH4YqNz3DUV5J5_sS4P7X7ZznFNETyQlLe0gonaSi3eE_jdjHD_aIjbPKhgpvUrkg6tPprYQYdwDGiyuWIXty9BOUlc07wUVbjDxI1bHoVxZA0ZCC9HBPjLXQwUioBSd9e9n-Z3uCeJ9UUgEvtJHLo1AllR20HGJETFdKoovxLBMw/s72-c/images.png)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html